Towards Healthcare

Healthcare Revenue Cycle Management Key Players | Innovation and Product Evolution | Market Entry and Expansion Strategies | Investment and Capital Allocation

Date : 17 January 2025

Healthcare Revenue Cycle Management Companies and Market Forecast

The global healthcare revenue cycle management market was estimated at US$ 136.40 billion in 2023 and is projected to grow to US$ 453.47 billion by 2034, rising at a compound annual growth rate (CAGR) of 11.54% from 2024 to 2034.

Top Companies in the Healthcare Revenue Cycle Management Market

  • Allscripts Healthcare, LLC
  • Cognizant
  • NextGen Healthcare
  • Experian
  • FinThrive
  • Ensemble Health Partners, Inc.
  • AGS Health Inc.
  • Dell Technologies
  • Adonis
  • Cerner Corporation
  • Athenahealth
  • Experion Information Solutions, Inc.
  • Change Healthcare
  • Conifer Health Solutions, LLC.
  • Optum
  • CareCloud, Inc.
  • Medical Information Technologies, Inc.
  • SSI Group Formativ Health
  • McKesson Corporation
  • R1 RCM, Inc.

Adonis in the Healthcare Revenue Cycle Management Market

Company Name Adonis
Headquarters NYC, U.S., North America
Recent Development In June 2024, Adonis, an automation and intelligence startup for the healthcare revenue cycle, revealed that it had raised $54 million in total, including $31 million in Series B investment. With participation from new investor Kin Ventures as well as returning investors General Catalyst, Max Ventures, and Bling Capital, Point72 Private Investments led the round.

Waystar in the Healthcare Revenue Cycle Management Market

Company Name Waystar
Headquarters U.S., North America
Recent Development In June 2024, the revenue cycle management software provider Waystar Holding Corp. started issuing 45 million shares of its common stock as part of its first public offering. Waystar anticipates giving the offering's underwriters a 30-day window during which they may choose to buy an additional 6,750,000 shares of common stock at the price of the first public offering (minus the underwriting discount). The price per share for the first public offering is projected to be between $20.00 and $23.00.